Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells

Fitoterapia

Volumn 86, Issue 1, 2013, Pages 19-28

  Choi, Hee Jung ^a   Jang, Hye Jin ^a   Chung, Tae Wook ^a   Jeong, Seung Il ^b   Cha, Jaeho ^a   Choi, Jun Young ^a   Han, Chang Woo ^a   Jang, Yong Suk ^c   Joo, Myungsoo ^a   Jeong, Han Sol ^a   Ha, Ki Tae ^a  

^a Pusan National University   (South Korea)

^b Jeonju Bio Materials Institute   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Advanced glycation end products; Catalpol; NF B; Reactive oxygen species; Rehmannia glutinosa

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIINFLAMMATORY AGENT; CATALPOL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REHMANNIA GLUTINOSA EXTRACT; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REHMANNIA; REHMANNIA GLUTINOSA; TRANSCRIPTION INITIATION;

BIOLOGICAL TRANSPORT; CELL LINE; DIABETES COMPLICATIONS; DRUGS, CHINESE HERBAL; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; IRIDOID GLUCOSIDES; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NADPH OXIDASE; NF-KAPPA B; PHOSPHORYLATION; PHYTOTHERAPY; PLANT ROOTS; REACTIVE OXYGEN SPECIES; REHMANNIA; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

REHMANNIA GLUTINOSA;

EID: 84876364069     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.01.014     Document Type: Article

References (62)

1. D.M. Nathan The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann Intern Med 124 1996 86 89
2. N. Ahmed Advanced glycation endproducts - role in pathology of diabetic complications Diabetes Res Clin Pract 67 2005 3 21
3. G. Basta, A.M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res 63 2004 582 592
4. M.P. Wautier, O. Chappey, S. Corda, D.M. Stern, A.M. Schmidt, and J.L. Wautier Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE Am J Physiol Endocrinol Metab 280 2001 E685 E694
5. R. Ramasamy, S.J. Vannucci, S.S. Yan, K. Herold, S.F. Yan, and A.M. Schmidt Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiology 15 2005 16R 28R
6. E.A. Abordo, and P.J. Thornalley Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts Immunol Lett 58 1997 139 147
7. S. Yamagishi, K. Nakamura, T. Matsui, S. Ueda, Y. Noda, and T. Imaizumi Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease Cardiovasc Ther 26 2008 50 58
8. S.Y. Goh, and M.E. Cooper The role of advanced glycation end products in progression and complications of diabetes J Clin Endocrinol Metab 93 2008 1143 1152
9. G.H. Baek, Y.S. Jang, S.I. Jeong, J. Cha, M. Joo, and S.W. Shin Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products Inflammation 35 2012 1232 1241
10. W.T. Chang, Y.H. Choi, R. Van der Heijden, M.S. Lee, M.K. Lin, and H. Kong Traditional processing strongly affects metabolite composition by hydrolysis in Rehmannia glutinosa roots Chem Pharm Bull 59 2011 546 552
11. J. Gao, B. Liu, J. Wang, X. Jin, R. Jiang, and L. Liu Spectroscopic investigation on assisted sonocatalytic damage of bovine serum albumin (BSA) by metronidazole (MTZ) under ultrasonic irradiation combined with nano-sized ZnO Spectrochim Acta A Mol Biomol Spectrosc 77 2010 895 901
12. S. Damtoft Biosynthesis of catalpol Phytochemistry 35 1994 1187 1189
13. W.J. Huang, H.S. Niu, M.H. Lin, J.T. Cheng, and F.L. Hsu Antihyperglycemic effect of catalpol in streptozotocin-induced diabetic rats J Nat Prod 73 2010 1170 1172
14. J.P. Shieh, K.C. Cheng, H.H. Chung, Y.F. Kerh, C.H. Yeh, and J.T. Cheng Plasma glucose lowering mechanisms of catalpol, an active principle from roots of Rehmannia glutinosa, in streptozotocin-induced diabetic rats J Agric Food Chem 59 2011 3747 3753
15. Y.Y. Tian, L.J. An, L. Jiang, Y.L. Duan, J. Chen, and B. Jiang Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures Life Sci 80 2006 193 199
16. B. Jiang, J. Du, J.H. Liu, Y.M. Bao, and L.J. An Catalpol attenuates the neurotoxicity induced by beta-amyloid(1-42) in cortical neuron-glia cultures Brain Res 1188 2008 139 147
17. C.F. Wang, D.Q. Li, H.Y. Xue, and B. Hu Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats Brain Res 1307 2010 158 165
18. J. Bi, B. Jiang, J.H. Liu, C. Lei, X.L. Zhang, and L.J. An Protective effects of catalpol against H2O2-induced oxidative stress in astrocytes primary cultures Neurosci Lett 442 2008 224 227
19. K.S. Park, B.H. Kim, and I.M. Chang Inhibitory potencies of several iridoids on cyclooxygenase-1, cyclooxygenase-2 enzymes activities, tumor necrosis factor and nitric oxide production in vitro Evid-Based Complement Alternat Med 7 2010 41 45
20. X.L. Zhang, A.H. Zhang, B. Jiang, Y.M. Bao, J.Y. Wang, and L.J. An Further pharmacological evidence of the neuroprotective effect of catalpol from Rehmannia glutinosa Phytomedicine 15 2008 484 490
21. H. Oshio, and H. Inouye Iridoid glycosides of Rehmannia glutinosa Phytochemistry 21 1982 133 138
22. W. Brandwilliams, M.E. Cuvelier, and C. Berset Use of a free-radical method to evaluate antioxidant activity Food Sci Technol-Lebensm-Wiss Technol 28 1995 25 30
23. K.K. Griendling, D. Sorescu, and M. Ushio-Fukai NAD(P)H oxidase - role in cardiovascular biology and disease Circ Res 86 2000 494 501
24. X.L. Chen, Q. Zhang, R. Zhao, and R.M. Medford Superoxide, H2O2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase Am J Physiol Heart Circ Physiol 286 2004 H1001 H1007
25. C.H. Yeh, L. Sturgis, J. Haidacher, X.N. Zhang, S.J. Sherwood, and R.J. Bjercke Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion Diabetes 50 2001 1495 1504
26. C.H. Wu, C.M. Huang, C.H. Lin, Y.S. Ho, C.M. Chen, and H.M. Lee Advanced glycosylation end products induce NF-kappaB dependent NOS expression in RAW 264.7 cells Mol and Cell Endo 194 2002 9 17
27. Y.W. Yoon, T.S. Kang, B.K. Lee, W. Chang, K.C. Hwang, and J.H. Rhee Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy Exp Mol Med 40 2008 398 406
28. Y. Iwashima, M. Eto, A. Hata, K. Kaku, S. Horiuchi, and F. Ushikubi Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages Biochem Biophys Res Commun 277 2000 368 380
29. S. Pennathur, and J.W. Heinecke Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy Front Biosci 9 2004 565 574
30. W. Cai, M. Torreggiani, L. Zhu, X. Chen, J.C. He, and G.E. Striker AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease Am J Physiol Cell Physiol 298 2010 C624 C634
31. C.H. Wu, C.F. Wu, H.W. Huang, Y.C. Jao, and G.C. Yen Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells Mol Nutr Food Res 53 2009 984 995
32. P. Reichard, B.Y. Nilsson, and U. Rosenqvist The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus N Engl J Med 329 1993 304 309
33. A.M. Schmidt, S.D. Yan, J.L. Wautier, and D. Stern Activation of receptor for advanced glycation end products - a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circ Res 84 1999 489 497
34. E.A. Omar, A. Kam, A. Alqahtani, K.M. Li, V. Razmovski-Naumovski, and S. Nammi Herbal medicines and nutraceuticals for diabetic vascular complications: mechanisms of action and bioactive phytochemicals Curr Pharm Des 16 2010 3776 3807
35. C.H. Wu, S.M. Huang, J.A. Lin, and G.C. Yen Inhibition of advanced glycation endproduct formation by foodstuffs Food Funct 2 2011 224 234
36. S.Y. Goh, and M.E. Cooper Clinical review: the role of advanced glycation end products in progression and complications of diabetes J Clin Endocrinol Metab 93 2008 1143 1152
37. B. Jiang, J.H. Liu, Y.M. Bao, and L.J. An Catalpol inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade Toxicon 43 2004 53 59
38. C. Rice-Evans Flavonoids and isoflavones: absorption, metabolism, and bioactivity Free Radic Biol Med 36 2004 827 828
39. R. Lu, Y. Gu, D. Si, and C. Liu Quantitation of catalpol in rat plasma by liquid chromatography/electrospray ionization tandem mass spectrometry and its pharmacokinetic study J Chromatogr B Analyt Technol Biomed Life Sci 877 2009 3589 3594
40. Q. Wang, M. Xing, W. Chen, J. Zhang, H. Qi, and X. Xu HPLC-APCI-MS/MS method for the determination of catalpol in rat plasma and cerebrospinal fluid: application to an in vivo pharmacokinetic study J Pharm Biomed Anal 70 2012 337 343
41. S.D. Yan, A.M. Schmidt, G.M. Anderson, J.H. Zhang, J. Brett, and Y.S. Zou Enhanced cellular oxidant stress by the interaction of advanced glycation end-products with their receptors binding-proteins J Biol Chem 269 1994 9889 9897
42. S. Yamagishi Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes Exp Gerontol 46 2011 217 224
43. J. Li, and A.M. Schmidt Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products J Biol Chem 272 1997 16498 16506
44. N. Shanmugam, Y.S. Kim, L. Lanting, and R. Natarajan Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products J Biol Chem 278 2003 34834 34844
45. S. Mahali, N. Raviprakash, P.B. Raghavendra, and S.K. Manna Advanced glycation end products (AGEs) induce apoptosis via a novel pathway: involvement of Ca2 + mediated by interleukin-8 protein J Biol Chem 286 2011 34903 34913
46. Y. Urata, M. Yamaguchi, Y. Higashiyama, Y. Ihara, S. Goto, and M. Kuwano Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages Free Radic Biol Med 32 2002 688 701
47. T. Okamoto, S. Yamagishi, Y. Inagaki, S. Amano, K. Koga, and R. Abe Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin FASEB J 16 2002 1928 1930
48. S.A. Park, H.K. Na, E.H. Kim, Y.N. Cha, and Y.J. Surh 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species Cancer Res 69 2009 2416 2424
49. C. Lopez-Pedrera, P. Buendia, M.J. Cuadrado, E. Siendones, M.A. Aguirre, and N. Barbarroja Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappa B/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway Arthritis Rheum 54 2006 301 311
50. J.H. Je, J.Y. Lee, K.J. Jung, B. Sung, E.K. Go, and B.P. Yu NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway FEBS Lett 566 2004 183 189
51. T. Jiang, Z. Huang, Y. Lin, Z. Zhang, D. Fang, and D.D. Zhang The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy Diabetes 59 2010 850 860
52. H. Zheng, S.A. Whitman, W. Wu, G.T. Wondrak, P.K. Wong, and D. Fang Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy Diabetes 60 2011 3055 3066
53. P. Palsamy, and S. Subramanian Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling Biochim Biophys Acta 1812 2011 719 731
54. B.H. Lee, W.H. Hsu, Y.Y. Chang, H.F. Kuo, Y.W. Hsu, and T.M. Pan Ankaflavin: a natural novel PPARgamma agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo Free Radic Biol Med 53 2012 2008 2016
55. J.T. Hancock, R. Desikan, and S.J. Neill Role of reactive oxygen species in cell signalling pathways Biochem Soc Trans 29 2001 345 350
56. T. Kakehi, and C. Yabe-Nishimura NOX enzymes and diabetic complications Semin Immunopathol 30 2008 301 314
57. S. Altenhofer, P.W. Kleikers, K.A. Radermacher, P. Scheurer, J.J. Rob Hermans, and P. Schiffers The NOX toolbox: validating the role of NADPH oxidases in physiology and disease Cell Mol Life Sci 69 2012 2327 2343
58. T. Ago, J. Kuroda, M. Kamouchi, J. Sadoshima, and T. Kitazono Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. Review and perspective Circ J 75 2011 1791 1800
59. E. Cifuentes-Pagano, G. Csanyi, and P.J. Pagano NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS Cell Mol Life Sci 69 2012 2315 2325
60. Y.J. Jang, J. Kim, J. Shim, S. Byun, M.H. Oak, and K.W. Lee Kaempferol attenuates 4-hydroxynonenal-induced apoptosis in PC12 cells by directly inhibiting NADPH oxidase J Pharmacol Exp Ther 337 2011 747 754
61. M. Gomez-Guzman, R. Jimenez, M. Sanchez, M.J. Zarzuelo, P. Galindo, and A.M. Quintela Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension Free Radic Biol Med 52 2012 70 79
62. E. Alvarez, B.K. Rodino-Janeiro, M. Jerez, R. Ucieda-Somoza, M.J. Nunez, and J.R. Gonzalez-Juanatey Procyanidins from grape pomace are suitable inhibitors of human endothelial NADPH oxidase J Cell Biochem 113 2012 1386 1396